Dr. Andrea Varrone has specialized in nuclear medicine since 1998 and obtained his PhD in functional radioisotopic imaging from the University “La Sapienza” of Rome, Italy in 2003. From 2007 to 2020, he worked at Karolinska Institute’s department of clinical neuroscience, first as assistant professor, then senior researcher in 2011 and docent and associate professor in nuclear medicine in 2012. Dr. Varrone´s research centers on the use of high-resolution PET and on methodological advancements in PET quantification and the application of PET for the identification of early biomarkers of motor/non-motor symptoms and disease progression in Parkinson’s disease. In November 2020, Dr. Varrone joined H. Lundbeck A/S and is now director of clinical biomarkers department. He is responsible for clinical PET and for coordinating biomarker implementation across projects and in Phase 1 and 2 clinical trials.